Kolexia
Guyader Dominique
Gastro-entérologie
Hôpital Pontchaillou
Rennes, France
128 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Hépatite Hépatite C Cirrhose du foie Hépatite C chronique Tumeurs du foie Carcinome hépatocellulaire Hépatite chronique Hépatite B

Industries

Servier
3 collaboration(s)
Dernière en 2020
MSD
2 collaboration(s)
Dernière en 2020
Abbvie
2 collaboration(s)
Dernière en 2021
CONGRES COLLOQUES CONVENTIONS
2 collaboration(s)
Dernière en 2020

Dernières activités

FIBR-OH: Interest of Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Didease in Alcoholic Patients in Weaning.
Essai Clinique (CHU Rennes)   19 mai 2023
HEPATHER: Therapeutic Option for Hepatitis B and C: a French Cohort
Essai Clinique (BMS)   30 janvier 2023
Acute hepatitis B virus infection despite vaccination in a patient treated by infliximab: a case report.
BMC gastroenterology   29 juin 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC infectious diseases   27 janvier 2022
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver international : official journal of the International Association for the Study of the Liver   17 janvier 2022
Corrigendum.
Alimentary pharmacology & therapeutics   27 octobre 2021
A case report of a therapeutic drug monitoring-guided sofosbuvir-velpatasvir crushed treatment
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Therapeutic Drug Monitoring-Guided Crushed Sofosbuvir-Velpatasvir Treatment: A Case Study.
Therapeutic drug monitoring   05 mai 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Clinics and research in hepatology and gastroenterology   27 avril 2021
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management.
Cancer prevention research (Philadelphia, Pa.)   19 février 2021